4//SEC Filing
Kochevar Deborah Turner 4
Accession 0001127602-21-023429
CIK 0001100682other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 11:47 AM ET
Size
11.7 KB
Accession
0001127602-21-023429
Insider Transaction Report
Form 4
Kochevar Deborah Turner
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-06$164.24/sh+2,539$417,005→ 9,622 total - Sale
Common Stock
2021-08-06$405.73/sh−901$365,562→ 8,721 total - Sale
Common Stock
2021-08-06$407.29/sh−5$2,036→ 6,096 total - Sale
Common Stock
2021-08-06$406.67/sh−2,620$1,065,473→ 6,101 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-08-06−2,539→ 0 totalExercise: $164.24From: 2021-05-11Exp: 2030-05-11→ Common Stock (2,539 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $405.18 to $406.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $406.19 to $407.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001448579
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 11:47 AM ET
- Size
- 11.7 KB